BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  AVITA Medical to Host Investor Webinar Briefing

  November 8, 2024

   · 

  2 min read
• Press Releases

  Paratek Pharmaceuticals Announces Positive Top-Line Data from Phase 2b Study of Oral Omadacycline (OMC) in Nontuberculous Mycobacterial (NTM) Abscessus Pulmonary Disease

  November 8, 2024

   · 

  7 min read
• Press Releases

  Natera to Participate in Upcoming Investor Conferences

  November 8, 2024

   · 

  1 min read
• Press Releases

  Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

  November 8, 2024

   · 

  18 min read
• Press Releases

  Spinal Muscular Atrophy Market to Hit US$ 4,823.9 Million by 2031, Coherent Market Insights

  November 8, 2024

   · 

  1 min read
• Press Releases

  Long Term Care Market to worth US$ 1,607.83 Billion by 2030, Coherent Market Insights

  November 8, 2024

   · 

  1 min read
• Press Releases

  Global Physiotherapy Services Market to Reach US$ 79.34 Billion by 2031, Coherent Market Insights

  November 8, 2024

   · 

  1 min read
• Press Releases

  Veterinary Services Market Size to worth US$ 192.98 Billion by 2031, Coherent Market Insights

  November 8, 2024

   · 

  1 min read
• Press Releases

  Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma

  November 8, 2024

   · 

  11 min read
• Press Releases

  BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024

  November 8, 2024

   · 

  3 min read